Merck & Company, Inc. vs Thermo Fisher Scientific Inc — Stock Comparison
Q·Score Breakdown
6.7
Neutral
Overall
7.8
Bullish
Quality
Health
Growth
Valuation
Sentiment
MRK
Forward P/E of 11.5× is low relative to sector peers.
TMO
Consensus analyst target of $620.13 is 32% above current price.
Analyst Consensus
BUY
Target $129.74 (+15.7%)
27 analysts
BUY
Target $620.13 (+32.2%)
24 analysts
Fundamentals
MRK
TMO
31.5×
Trailing P/E
25.8×
11.5×
Forward P/E
17.1×
13.6%
Profit Margin
15.2%
76.6%
Gross Margin
40.9%
—
ROE
13.5%
4.9%
Revenue Growth
6.2%
—
Earnings Growth
11.3%
0.28
Beta
0.97
—
Price / Book
—
$277.0B
Market Cap
$174.4B
$73 – $125
52-Week Range
$385 – $644
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →